Review of remote ischemic conditioning for ischemic stroke highlights mechanistic targets and clinical variability.

This narrative review evaluates the potential role of remote ischemic conditioning (RIC) in the context of ischemic stroke. The scope encompasses mechanistic pathways and clinical trial data, though specific study populations and sample sizes are not reported. The authors synthesize findings indicating that RIC may modulate neuroinflammation, preserve the blood-brain barrier, and promote angiogenesis and remyelination. Additionally, the review highlights the suppression of pyroptosis, apoptosis, ferroptosis, and disulfidptosis as potential biological effects.

The authors report that clinical efficacy is heterogeneous across trials. Therapeutic outcomes are significantly influenced by circadian rhythms, baseline systemic inflammation, and levels of lipoprotein(a) and mean corpuscular hemoglobin (MCH). No specific effect sizes, absolute numbers, or p-values are provided in this synthesis. Safety data, including adverse events and tolerability, were not reported in the source material.

Key limitations identified include the heterogeneous efficacy observed in clinical trials and the dependence on specific execution protocols and successful cerebral reperfusion. The review suggests that standardization of treatment protocols and the use of precision medicine to identify optimal responders are necessary. Integration with existing therapies is proposed to maximize long-term stroke recovery, though practice relevance is tempered by the current lack of standardized protocols.